<DOC>
	<DOC>NCT00654680</DOC>
	<brief_summary>Investigate efficacy and safety of Vardenafil in patients with spinal cord injury</brief_summary>
	<brief_title>Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Males ≥18 years with erectile dysfunction (ED) solely as a result of traumatic spinal cord injury (SCI) for ≥6 months with demonstrated 50% failure in intercourse attempts during the 4week runin period. Stable heterosexual relationship for at least 1 month. Subjects with unstable medical or psychiatric conditions or using prohibited concomitant medications Primary hypoactive sexual desire History of myocardial infarction, stroke or lifethreatening arrhythmia within prior 6 month Nitrate therapy Other exclusion criteria apply according to US Product Information or Summary of Product Characteristics</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Traumatic spinal cord injury</keyword>
	<keyword>Vardenafil</keyword>
</DOC>